Long COVID: neurological manifestations - an updated narrative review
Authors:
- José Wagner Leonel Tavares-JúniorJTJosé Wagner Leonel Tavares-Júnior
- Gabriella Cunha Vieira CiurleoGCGabriella Cunha Vieira Ciurleo
- Alissa Moura FormigaAFAlissa Moura Formiga
- Thais de Maria Frota VasconcelosTVThais de Maria Frota Vasconcelos
- Marcello Holanda de AndradeMAMarcello Holanda de Andrade
- Werbety Lucas Queiroz FeitosaWFWerbety Lucas Queiroz Feitosa
- Antônio Alves Sobreira-NetoASAntônio Alves Sobreira-Neto
- Chiara Gübel PortugalCPChiara Gübel Portugal
- Lorenzo Marinho MoraisLMLorenzo Marinho Morais
- Samuel Cavalcante MarinhoSMSamuel Cavalcante Marinho
- Emanuel de Assis Bertulino Martins GomesEGEmanuel de Assis Bertulino Martins Gomes
- Esther de Alencar Araripe Falcão FeitosaEFEsther de Alencar Araripe Falcão Feitosa
Open Access
- 1 January 2024
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 18, e20230076
Abstract
Infection with the SARS-CoV-2 virus can lead to neurological symptoms in the acute phase and in the Long COVID phase. These symptoms usually involve cognition, sleep, smell disorders, psychiatric manifestations, headache and others. This condition is more commonly described in young adults and women. This symptomatology can follow severe or mild cases of the disease. The importance of this issue resides in the high prevalence of neurological symptoms in the Long COVID phase, which entails significant morbidity in this population. In addition, such a condition is associated with high health care costs, with some estimates hovering around 3.7 trillion US dollars. In this review, we will sequentially describe the current knowledge about the most prevalent neurological symptoms in Long COVID, as well as their pathophysiology and possible biomarkers.Keywords
Funding Information
- Coordination for the Improvement of Higher Education Personnel - Brazil (88881.505364/2020-01)
This publication has 61 references indexed in Scilit:
- Into the looking glass: Post-viral syndrome post COVID-19Medical Hypotheses, 2020
- The landscape of cognitive function in recovered COVID-19 patientsJournal of Psychiatric Research, 2020
- Neuropsychological functioning in severe acute respiratory disorders caused by the coronavirus: Implications for the current COVID-19 pandemicThe Clinical Neuropsychologist, 2020
- COVID‐19‐related encephalopathy: a case series with brain FDG‐positron‐emission tomography/computed tomography findingsEuropean Journal of Neurology, 2020
- Narcolepsy and COVID-19: sleeping on an opportunity?Journal of Clinical Sleep Medicine, 2020
- Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patientsNeurological Sciences, 2020
- Neurologic Features in Severe SARS-CoV-2 InfectionNew England Journal of Medicine, 2020
- Systemic Inflammation and the Brain: Novel Roles of Genetic, Molecular, and Environmental Cues as Drivers of NeurodegenerationFrontiers in Cellular Neuroscience, 2015
- Risk of Narcolepsy Associated with Inactivated Adjuvanted (AS03) A/H1N1 (2009) Pandemic Influenza Vaccine in QuebecPLOS ONE, 2014
- Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C miceVirology, 2006